Monthly Archives: October 2012

New bacteria to fight against intestinal inflammation

Élafine (en vert) libérée par la bactérie recombinante à la surface du colon d'une souris traitée. En rouge, les cellules épithéliales. En bleu, les noyaux cellulaires.

Nathalie Vergnolle, director of research at Inserm, and her team at the Centre for Physiopathology at Toulouse Purpan (CPTP Inserm / Université Toulouse III – Paul Sabatier /CNRS), with Philippe Langella director of research at INRA and his team at the Institut Micalis[1], in collaboration with the Institut Pasteur, have recently succeeded in producing “beneficial bacteria” capable of protecting the body against intestinal inflammation.

Chickenpox is on the way back

Created over twenty-five years ago, the Sentinel Network is a health watch network that uses data collected from 1300 family physicians based in mainland France. Thanks to the data communicated in real-time by Sentinel physicians, the Network is able to publish a weekly report of the chickenpox, gastroenteritis and influenza epidemics and can forecast the trends for the forthcoming weeks.

October 31th 2012

Sorry, this article is only available in French.

October 30th 2012

Sorry, this article is only available in French.

The HOIL1 gene – the cause of a new rare disease

The researcher Capucine Picard, working with the team from Inserm unit 980 “Human genetics and infections diseases” has succeeded in identifying the part played by the HOIL1 gene in cases of paradoxal association of an immune deficiency with a chronic autoinflammatory deficiency and a muscular deficiency in 3 children from 2 different families.

October 29th 2012

Sorry, this article is only available in French.

Monday 29 October: World Cardiovascular Disease Day

L’AVC constitue l’une des premières causes de mortalité en France avec, 150 000 cas détectés chaque année, soit 1 toutes les 4 minutes.

This weekend, the clocks go back: is seasonal affective disorder in store for us?

Dans la nuit de samedi 27 à dimanche 28 octobre, la France passera à l’heure d’hiver.

New developments reveal a molecule with a promising function in terms of cancer treatment

Researchers from Inserm and CNRS from the Institute for genetics and molecular and cellular biology (IGBMC) and from the Research Institute at the Strasbourg school of biotechnology (Irebs) have focussed their efforts on PARG, currently thought to be a promising new therapeutic target in the treatment of cancer.

October 26th 2012

Sorry, this article is only available in French.

RSS Youtube